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Abstract
Background: Murcia (south-east Spain) shows increased cardiovascular (CV) morbimortality as compared to other
Spanish regions. Our objective was to assess the CV risk associated with major risk factors (RF) among adult
population of Murcia.
Methods: A cohort of 2314 subjects (18-70 years) with full biochemical and questionnaire data was followed-up
for 13 years. Incident cases of ischemic heart disease and stroke were identified by record linkage, individual
questionnaires and revision of medical records. Relative risks were obtained by multivariate Cox regression stratified
by age and sex, and ischemic risk attributable to CVRF was calculated.
Results: After more than 26276 person-years of follow-up, 57 incident ischemic events (77% men) and 37 stroke
cases (62% men) were identified. Independent risk factors of ischemic heart disease (IHD) and all CV events
combined, with RR ranging from 1.6 to 2.6, were total serum cholesterol ≥ 240 mg/dl (HR = 2.6, 95%CI:1.3-5.1),
blood pressure levels ≥ 140/90 mmHg (HR = 2.6, 95%CI:1.4-4.8), ever tobacco smoking (HR = 2.2; 95%CI:1.1-4.5),
and diabetes (HR = 2.0; 95%CI: 1.0-3.8). No increased CV risk was detected for known participants under treatment
who showed cholesterol and blood pressure values below the clinical risk threshold. Smoking was significantly
associated with stroke. For all events combined, the major risk factors were hypercholesterolemia, hypertension and
ever use of tobacco. Despite its high prevalence, obesity was not associated to CV risk. Most of the IHD cases were
attributable to smoking (44%), hypertension (38%) and hypercholesterolemia (26%).
Conclusions: In the Region of Murcia, smoking accounted for the largest proportion of cardiovascular risk, whereas
hypertension displaced hypercholesterolemia as the second leading cause of CV disease. Our study deepens in our
understanding of the cardiovascular epidemiology in Spanish areas of Mediterranean Europe with relatively high
cardiovascular morbimortality, that are poorly represented by the available risk equations.
Background
The Spanish Region of Murcia is located in the Mediter-
ranean basin, one of the areas with the lowest rates of
cardiovascular disease (CVD) mortality in Europe [1].
However, the burden of CVD is high in Murcia as com-
pared to other Spanish regions [2], yet still low in an
international context. The prevalence of CVRF is also
high, as characteristic in Spain [3-5], albeit the diet pre-
serves cardiovascular-healthy Mediterranean traits [6].
Cardiovascular prevention is a Public Health priority in
the region, as well as the rest of the country.
The evaluation and prioritization of Public Health
interventions for controlling CVD rely on estimates of
population risk attributable to CVRF [7]. Obtaining such
indicators requires knowing in anticipation both the
prevalence of RF in the community and the associated
relative risks, ideally coming from population-based pro-
spective studies. From an individual perspective,
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chance of suffering a CV event within a certain period
of time [8-10]. Those nowadays available in Spain, how-
ever, rely on risk estimates available for the USA (REGI-
COR) [8] or European (SCORE) [9] populations. Both,
REGICOR and SCORE are calibrations of the Framing-
ham and SCORE risk functions, respectively, but only
the first has been validated for use in Spain [11]. How-
ever, a specific risk chart for the country is not yet avail-
able that takes regional variability into account, in spite
of the reiterated claims that risks systematically used in
clinical practice [8-10] overestimate the CV risk of the
Spanish population [11,12].
The scarce prospective literature available in Spain
[13,14] confirms an elevated IHD risk for hypercholes-
terolemia and tobacco smoking, whereas associations for
hypertension, overweight or diabetes are less consistent.
The objective of the present study was to estimate
specific CVD risk associated with major CVRF and the
attributable risk of IHD in a representative sample of
population from Murcia [15].
Methods
Study sample and design
This longitudinal prospective population-based study
comprises a cohort of 3089 men and women, aged 18-
70 years, who were recruited from November 1991 until
March 1993. A random representative sample of the
Murcia population was selected with clustering by
(administrative) health area and sampling quota were
defined by type of residence (rural/urban), age group
and sex, with the aim of surveying the regional preva-
lence of CVRF. Participants were contacted by mail, tel-
ephone or home visit. Baseline questionnaire
information was obtained on clinical and lifestyle char-
acteristics and subjects were invited to undergo a physi-
cal examination. Furthermore, 78% of participants
provided a fasting blood sample for serum lipid analysis
(Figure 1). A more detailed description of the methodol-
ogy has been published elsewhere [15].
All participants voluntarily agreed to take part in the
study, in compliance with the Declaration of Helsinki.
The information collected was treated as confidential
and the databases were registered at the Spanish Data
Protection Authority as stipulated by law. The study was
conducted with the approval of the Ethics Committee of
the Virgen de la Arrixaca Hospital (Murcia), the main
regional hospital.
Baseline data collection
A questionnaire administered by trained personnel was
used to gather information on sociodemographic, life-
style and health-related factors. Interviews took place in
primary care institutions and local public centers.
Questions on medical history and smoking habit
included were those of the MONICA study [16]. The
highest academic attainment of participants (illiterate,
non-primary, primary, secondary, or higher) was regis-
tered. Recent physical activity for the last two weeks was
assessed by asking the frequency and duration of mod-
erate and vigorous sporting activities, by separate, using
a validated questionnaire [17]. During a physical exami-
nation, participants had their blood pressure measured
and height and weight registered according to MONICA
standards. Calibrated mercury sphygmomanometers
(Riester 660/306, model Diplomat, Germany) were used
for blood pressure measurement and systolic and diasto-
lic values were defined as the mean of two consecutive
readings. Weight and height were assessed for subjects
barefoot in light clothing, using calibrated equipment.
Body mass index (BMI) was calculated as weight (in kg)
divided by square height (in m).
Total serum cholesterol and triglyceride concentra-
tions were analysed by enzymatic methods in a Hitachi
autoanalyzer (model 717) at the Department of Clinical
B i o c h e m i s t r yo ft h eV i r g e nd el aA r r i x a c aU n i v e r s i t y
Hospital (Murcia). The apparatus coefficients of
Figure 1 Study sample flow-chart. Definite AMI criterion based on
the MONICA diagnostic classification [18]. AMI: acute myocardial
infarction. TIA: transient ischemic attack.
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2.2% for triglycerides.
Definition of risk factors
Hypercholesterolemia was defined as total serum choles-
terol ≥240 mg/dl (6.2 mmol/l), a previous diagnosis of
elevated cholesterol or prescribed use of lipid-lowering
drugs. Hypertriglyceridemia was defined as serum trigly-
cerides ≥150 mg/dl (1.7 mmol/l). Hypertension was
defined as mean systolic blood pressure ≥140 mmHg or
mean diastolic blood pressure ≥90 mmHg, a previous
diagnosis of hypertension or use of anti-hypertensive
medication. ‘Ever smokers’ included current and former
smokers. Diabetes and use of anti-diabetic drugs were
self-reported. Normal weight (<25 kg/m
2), overweight
(25-29.9 kg/m
2)a n do b e s i t y( ≥30 kg/m
2) were defined
according to BMI.
Follow-up and identification of CVD cases
Retrospective information on newly diagnosed cases of
angina, AMI and stroke, and vital status of the cohort,
was collected between November 2005 and June 2006
for more than 99% of the sample, completing a mean
follow-up of 13.1 (± 1.5) years. Occurrence and dates of
new cardiovascular events were recorded for 2023 parti-
cipants after excluding subjects with missing data on
study variables (N = 775) and those lost to follow-up (N
= 291; 12.6%).
The identification of cases was carried out through a
multiple strategy: a) contact with participants by
postal or telephone interview to register self-reported
r i s kf a c t o r so rC Ve v e n t sd i a g n o s e db yap h y s i c i a n ,
and dates and causes of hospital admissions during
the last ten years; b) record linkage with hospital dis-
charge databases of all public hospitals in Murcia and
the regional Mortality Register; c) revision of the med-
ical history of all participants with hospital admission
due to any of the following ICD-9 codes: 250-250.93,
272-272.9, 278.0-278.01, 401-405.99, 410-414.9, 420-
429.9, 430-438.9, or 797-799.9; d) revision of the med-
ical history, either in the corresponding primary care
centre or the reference hospital, of all dead partici-
pants due to any of the following ICD-10 codes: E10-
E11.9, E66-E66.9, E78-E78.9, G45-G46.8, I10-I11.9,
I20-I25.9, I46-I46.9, I50-I50.9, I61-I64, I67-I67.9, R96-
R96.1, or R98, as well as all those participants alive
who self-reported any risk factor or CV event in the
follow-up interview. Events were classified according
to MONICA criteria [18].
Cases were censored at the date of diagnosis of the
CV event. Non-cases were censored at date of a non-
cardiovascular death or at follow-up data collection.
Statistical analyses
The distribution of variables by sex was summarised as
median values and interquartile range or percentages.
Because of the lack of normality of continuous variables,
the Kruskall-Wallis test was used to check for statistical
differences in the distribution of data between men and
women, whereas c
2 test were used to assess whether
categorical variables were proportionally distributed by
sex.
Hazard ratios (HR) of CVD by levels of risk factors
were obtained using Cox regression models with age as
the underlying time variable. The proportional-hazards
assumption was tested on the basis of Schoenfeld resi-
duals using the estat phtest command in STATA. No
significant violations of the proportionality assumption
were detected. Due to the limited number of cases
among women, sex was used as a stratifying variable in
Cox models instead of presenting disaggregated results
for men and women. Regression models were further
stratified by 5-year age categories in order to account
for differences in baseline hazard functions by age
group. Trend P values for cholesterol and BMI levels
were computed by entering the variables in the models
as continuous with increasing categories coded by con-
secutive integer values. Het e r o g e n e i t yb ys e xi nC V D
r i s kf o re a c hr i s kf a c t o rw a se s t a b l i s h e do nt h eb a s i so f
the P value of a likelihood ratio test between models
with and without the risk factor × sex interaction term.
Prevalent cases of IHD (N = 23) were excluded from
the analysis of angina and AMI end-points, whereas par-
ticipants with a prevalent stroke (N = 8) were excluded
from models of cerebro-vascular risk. The analysis of all
CV events combined finally excluded all participants
with any prevalent CV condition at baseline and cen-
sored their follow-up time at the date of diagnosis of
the first CV event.
The Population Attributable Risk (PAR) was calcu-
lated according to the formula: pE(RR - 1)/(1 + pE(RR -
1)) [19], where pE denotes the prevalence of exposition
to every individual risk factor based on results of the
DINO Study (2002) [5], the most updated population-
based survey on chronic morbidity available in Murcia,
and RR denotes the multivariate-adjusted relative risk as
estimated by the HR of multivariate Cox regression in
the present study [15]. In order to prevent PAR esti-
mates from being influenced by age, risk factor preva-
lences were standardised to the age distribution of the
Murcia population according to the 2001 census and
truncated to the age range of the current study (20-70
years).
All analyses were performed with STATA/SE version
10.1. Level of statistical significance was set at 5%.
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A total of 71 incident cases of IHD were identified (34
cases of angina and 37 cases of AMI). Fourteen AMI
cases (38%) had had a previous episode of angina.
Furthermore, a cerebro-vascular event was diagnosed in
37 participants (Figure 1). Three out of four ischemic
events (77%) and two out of three stroke cases detected
(62%) were in men
Table 1 summarises relevant clinical variables by sex.
On average, participants were middle-aged (≈40 years)
and overweight. The distribution of CV risk factors dif-
f e r e db ys e x ,e x c e p tf o rs e l f - r e p o r t e dd i a b e t e s .M e n
showed a less favourable lipid profile than women,
higher prevalence of hypertension, and more frequently
engaged in sporting activities. Among those people that
reported being under treatment either for high serum
cholesterol or blood pressure, men were more often
found uncontrolled. A lower percentage of women had
completed secondary or university studies, and fewer
women smoked. Although no overall differences in aver-
age body mass index were observed by sex, a higher per-
centage of men were overweight whereas a larger
proportion of women were obese.
Table 2 shows the hazard ratios of cardiovascular
events by defined categories of CVRF. Overall, IHD was
associated to elevated serum cholesterol and blood pres-
sure levels, diabetes and present or past smoker condi-
tion. In separate analyses, higher lipid concentrations
were significantly associated with AMI, whereas no fac-
tor reached statistical significance as predictor of angina.
Smoking was additionally strongly associated to stroke.
For all CV events combined, smoking and hypertension
were independently and significantly associated with an
elevated risk of suffering a CV event of any kind. A pos-
sible association with hypertriglyceridemia and diabetes
remained above the threshold of, but close to, statistical
significance. Overweight or obese participants showed
no increased CV risk in this cohort neither in univariate
nor in fully adjusted models. Body mass index was also
tested as a continuous or binary (non-obese/obese) vari-
able and results did not substantially change. As for
gender differences in CV risk profile, heterogeneity by
sex was lower for stroke than it was for IHD.
Uncontrolled hypercholesterolemia and hypertension
were prognostic of IHD but not stroke (albeit results
were suggestive of a higher stroke risk among the hyper-
tensive participants, this association remained non-sig-
nificant), as shown in Table 3. As compared to healthy
subjects, no increased CV risk was detected for pre-
viously diagnosed participants who showed cholesterol
and blood pressure values below the clinical threshold.
The estimated population risk attributable to each
CVRF (and 95%CI) is presented in Table 4. Smoking
accounted for the largest proportion of IHD cases
(45%), followed by hypertension (33%) and, to a lesser
extent, hypercholesterolemia (22%). According to the
formula PAR = 1 - (1 - PARrisk factor 1) × (1 - PARrisk fac-
tor 2) × ... × (1 - PARrisk factor n), it can be estimated that
these three factors together account for 1 - (1 - 0.45) ×
(1 - 0.33) × (1 - 0.22) = 71% of IHD cases.
The results of the comparison of baseline characteris-
tics between subjects finally included in the analyses and
those who were lost to follow-up is presented as supple-
mentary data [Additional File 1: Table S1]. Overall,
there were no significant differences between groups
except that lost to follow-up participants more fre-
quently smoked and, despite no significant differences
in serum cholesterol distributions were found, were less
prone to be hypercholesterolemic than participants
included in the analysis.
The age-standardised cumulative incidence rates of
AMI and stroke in the Murcia population is shown in
supplementary data [Additional File 1: Table S2]. Men
s u f f e r e df r o mi n c r e a s e di n c i d e n c eo fb o t hc o n d i t i o n st o
a larger extent than women. Generally men presented
higher rates of AMI than stroke, whereas women
showed low rates of AMI, and higher incidence of
stroke. Truncated age-standardised incidence AMI rates
per 100000 person-years were 403 in men and 124 in
women for the 35-64 years age range. Incidence rates of
stroke for the same age group were 243 and 221 per
100000 person-years for men and women, respectively.
Discussion
CVD remain as the leading cause of mortality in Spain
[20], and Murcia, despite its Mediterranean location,
shows incidence and mortality rates of CVD above the
Spanish average [2,21,22]. In the present study, age-
standardised incidence AMI rates were higher than pre-
viously reported by the IBERICA Study (1997-1998), a
population-based registry of AMI [2]. However, coron-
ary mortality is decreasing in Spain, and the high rates
found in the present study would partly reflect this
more unfavourable CV pattern of the past decade
[21,23].
Our analysis revealed that hypertension and tobacco
use are the most important CVRF in Murcia. Further-
more, hypercholesterolemia and diabetes were associated
to IHD, and hypertriglyceridemia to AMI. The baseline
prevalence of hypertension in Murcia was below the
c o u n t r ya v e r a g e ,b u tt h e r ew a sal a r g e rp r o p o r t i o no f
current smokers [3,24]. During the 1992-2002 period
there was an overall favourable evolution of the CV risk
profile of the population, with significant reductions in
the prevalence of smoking and hypertension, increased
percentage of people engaging in regular physical
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region, in spite of which hypercholesterolemia increased
by 30% [25]. However, changes in the exposition levels
over time were not assessed in the members of the
cohort and could not be accounted for in the analyses.
According to our results, the risk of IHD was two- to
three-fold higher in subjects with high cholesterol or
blood pressure values, ever smokers and diabetics. Of
note, hypertriglyceridemia, a factor systematically
excluded from CV risk charts and equations [8-10], was
Table 1 Distribution of cardiovascular risk factors by sex among cohort participants (≥18 years)
Men (N = 956) Women (N = 1067)
Median IQR Median IQR P
Age at recruitment (years) 39.3 19.5 40.5 19.0 0,699
Body mass index (kg/m
2) 26.7 4.7 26.3 6.6 0,572
Total serum cholesterol (mg/dl) 196.0 63.5 186.0 63.0 <0,001
Serum triglycerides (mg/dl) 118.0 86.5 84.0 51.0 <0,001
Systolic blood pressure (mmHg) 129.0 20.0 121.0 24.0 <0,001
Diastolic blood pressure (mmHg) 79.0 16.0 76.0 16.0 <0,001
N% N %P
Hypercholesterolemia
a No 664 69.5 792 74.2
Controlled 100 10.5 105 9.8
Uncontrolled 164 17.2 143 13.4 0.040
Unknown
d 28 2.9 27 2.5
Triglyceridemia <150 mg/dl 650 68.0 943 88.4
≥150 mg/dl 306 32.0 124 11.6 <0,001
Educational level Illiterate 19 2.0 47 4.4
Incomplete primary 255 26.7 374 35.1
Primary shool 394 41.2 428 40.1
Secondary school 165 17.3 130 12.2
University 123 12.9 88 8.2 <0,001
Hypertension
b No 562 58.8 695 65.0
Controlled 60 6.3 101 9.4
Uncontrolled 310 32.4 265 24.8 <0,001
Unknown
d 24 2.5 9 0.8
Diabetes
c No 859 89.9 945 88.6
Yes 74 7.7 103 9.7 0,140
Unknown
d 23 2.4 19 1.8
Smoking Non-smoker 309 32.3 740 69.4
Former smoker 132 13.8 37 3.5
Smoker 515 53.9 290 27.2 <0,001
Body mass index <25 kg/m
2 293 30.7 413 38.7
25-29.9 kg/m
2 485 50.7 378 35.4
≥30 kg/m
2 178 18.6 276 25.9 <0,001
Moderate physical activity None 722 80,8 972 91,1
<1/2 h/day 97 10,2 54 5,1
≥1/2 h/day 87 8,1 41 3,8 <0,001
Intense physical activity None 830 86,8 1011 94,8
<2 h/day 40 4,2 19 1,8
≥2 h/day 86 9,0 37 3,5 <0,001
IQR: Interquartile range (Q3 -Q 1).
aControlled hypercholesterolemia defined as prior diagnosis of hypercholesterolemia or use of lipid-lowering medication and total serum cholesterol <240 mg/dl;
uncontrolled hypercholesterolemia defined as total serum cholesterol ≥240 mg/dl.
bControlled hypertension defined as prior diagnosis of hypertension or use of anti-hypertensive medication and systolic/diastolic blood pressure <140/90 mmHg;
uncontrolled hypertension defined as systolic/diastolic blood pressure ≥140/90 mmHg.
cDefined as a self-reported diagnosis of diabetes or prescription of insulin or oral anti-diabetic medication.
dParticipants with missing data on drug use, excluded from statistical tests.
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Page 5 of 10Table 2 Risk of incident cardiovascular disease in a cohort of adult population from Murcia (south-east Spain)
Ischemic heart disease Stroke All events
Angina AMI All ischemic events
Py/
cases
HR (95% CI) Py/
cases
HR (95% CI) Py/
cases
HR (95% CI) Py/
cases
HR (95% CI) Py/
cases
HR (95% CI)
Total cholesterol
(mg/dl)
<200 15393/
10
1 15404/8 1 15381/
16
1 15454/
19
1 15308/
31
1
200-239 7154/8 1.14 (0.43-
3.05)
7182/7 0.83 (0.29-
2.39)
7138/12 0.97 (0.44-
2.11)
7232/9 0.54 (0.23-
1.28)
7104/18 0.71 (0.39-
1.29)
≥240 3814/16 2.27 (0.91-
5.68)
3813/22 2.85 (1.16-
6.99)
3757/29 2.59 (1.30-
5.14)
3913/9 0.79 (0.33-
1.90)
7105/32 1.61 (0.92-
2.81)
P for trend (categorical) P = 0.075 P = 0.009 P = 0.005 P = 0.459 P = 0.119
Pheterogneity by sex =
0.071
Pheterogneity by sex =
0.500
Pheterogneity by sex =
0.024
Triglycerides (mg/dl)
<150 20902/
17
1 20947/
14
1 20868/
28
1 21041/
26
1 20768/
44
1
≥150 5459/17 1.64 (0.77-
3.50)
5452/23 2.48 (1.17-
5.27)
5408/29 1.64 (0.91-
2.94)
5558/11 0.83 (0.39-
1.79)
5369/37 1.52 (0.94-
2.47)
Pheterogneity by sex =
0.035
Pheterogneity by sex =
0.003
Pheterogneity by sex =
0.009
Blood pressure (mm Hg)
<140/90 19212/
12
1 19151/9 1 19103/
17
1 19258/
13
1 19067/
25
1
≥140/90 2.12 (0.95-
4.71)
7248/28 3.68 (1.62-
8.34)
7172/40 2.59 (1.39-
4.84)
7341/24 1.92 (0.91-
4.01)
7070/56 2.44 (1.46-
4.07)
Pheterogneity by sex =
0.040
Pheterogneity by sex =
0.964
Pheterogneity by sex =
0.101
Diabetes
a
No 23620/
23
1 23627/
28
1 23553/
40
1 23820/
29
1 23449/
61
1
Yes 2179/9 2.04 (0.95-
4.71)
2199/9 1.77 (0.79-
3.97)
2162/15 1.98 (1.02-
3.83)
2216/7 1.45 (0.60-
3.47)
2135/18 1.67 (0.96-
2.92)
Pheterogneity by sex =
0.004
Pheterogneity by sex =
0.483
Pheterogneity by sex =
0.010
Ever smoking
No 13623/
15
1 13660/
13
1 13597/
21
1 13723/
16
1 13526/
32
1
Yes 2070/19 1.93 (0.78-
4.74)
12739/
24
1.94 (0.84-
4.51)
12679/
36
2.22 (1.10-
4.46)
12875/
21
3.88 (1.31-
11.50)
12610/
49
2.39 (1.31-
4.38)
Pheterogneity by sex =
0.010
Pheterogneity by sex =
0.716
Pheterogneity by sex =
0.030
BMI categories
b
Normal weight 9328/4 1 9324/5 1 9317/7 1 9387/4 1 9306/10 1
Overweight 11221/
18
1.07 (0.33-
3.41)
11232/
24
0.82 (0.29-
2.33)
1176/33 1.06 (0.44-
2.52)
11346/
16
2.61 (0.72-
9.42)
11114/
43
1.29 (0.62-
2.66)
Obese 5811/12 0.91 (0.26-
3.18)
5843/8 0.38 (0.11-
1.27)
5783/17 0.76 (0.29-
1.99)
5866/17 2.56 (0.69-
9.48)
5717/28 1.08 (0.50-
2.34)
P for trend (categorical) P = 0.801 P = 0.065 P = 0.455 P = 0.216 P = 0.950
-
c -
c -
c
AMI: Acute myocardial infarction; Py: Person-years. HR: Hazard ratio. CI: confidence interval.
Cox models adjusted by all variables in the table, plus educational level and physical activity of moderate and high intensity, and stratified by sex and age.
aDefined as a self-reported diagnosis of diabetes or prescription of insulin or oral anti-diabetic medication.
bNormal weight: Body mass index (BMI) <24.9 kg/m
2; overweight: 25 ≤ BMI < 29.9 kg/m
2; obese: BMI ≥30 kg/m
2.
cHeterogeneity by sex cannot be assessed because the lack of cases in the reference category for women prevents fitting a regression model.
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of almost similar magnitude to that of serum choles-
terol, in agreement with previous evidence in Spain [26].
On the other hand, information on diabetes was based
on participants’ self-reports, which are known to under-
represent the true prevalence of the condition in our
population [27]. Thus, the CV risk assessed for diabetes
might be under-estimated and should be considered
with caution. Virtually no data exist in Spain on the
prospective association between CVRF and incidence of
ischemic or cerebro-vascular events. A study by Marín
et al. [13] found lower risk estimates than the present
Table 3 Risk of incident cardiovascular disease associated to hypercholesterolemia and hypertension in a cohort of
adult population from Murcia (south-east Spain)
Ischemic heart disease Stroke All events
Angina AMI All ischemic events
Py/
cases
HR (95%CI) Py/
cases
HR 95%CI Py/
cases
HR 95%CI Py/
cases
HR 95%CI Py/
cases
HR 95%CI
Hypercholesterolemia
a
No 19194/
12
1 19213/
10
1 19170/
19
1 19288/
20
1 19113/
37
1
Controlled 2609/5 1,22 (0,39-
3,81)
2629/4 1,30 (0,39-
4.37)
2606/7 1,18 (0,47-
2,96)
2676/7 1,44 (0,56-
3,67)
2578/11 1,08 (0,53-
2,24)
Uncontrolled 3814/16 2,20 (0.94-
5.16)
3813/22 3,57 (1,57-
8.12)
3757/29 2,83 (1,49-
5,37)
3913/9 1,08 (0,45-
2,60)
3724/32 1.89 (1,11-
3,23)
Pheterogneity by sex =
0.789
Pheterogneity by sex =
0.097
Pheterogneity by sex =
0.217
Hypertension
b
No 16631/7 1 16633/7 1 16614/
12
1 16683/9 1 16580/
18
1
Controlled 2043/4 3,32 (0,89-
12,36)
2069/2 1,80 (0,36-
9,17)
2040/5 2,71 (0,90-
8,12)
2126/4 1,98 (0,56-
6.98)
2037/7 2,22 (0,89-
5,54)
Uncontrolled 7238/23 2,78 (1,10-
7,08)
7248/28 4,06 (1,64-
10.03)
7172/40 3,15 (1,55-
6,40)
7341/24 2,31 (0.98-
5,43)
7070/56 2,85 (1,60-
5,06)
Pheterogneity by sex =
0.030
Pheterogneity by sex =
0.995
Pheterogneity by sex =
0.053
AMI: Acute myocardial infarction; Py: Person-years. HR: Hazard ratio. CI: confidence interval.
aControlled hypercholesterolemia defined as prior diagnosis of hypercholesterolemia or use of lipid-lowering medication and total serum cholesterol <240 mg/dl;
uncontrolled hypercholesterolemia defined as total serum cholesterol ≥240 mg/dl.
bControlled hypertension defined as prior diagnosis of hypertension or use of anti-hypertensive medication and systolic/diastolic blood pressure <140/90 mmHg;
uncontrolled hypertension defined as systolic/diastolic blood pressure ≥140/90 mmHg.
Table 4 Population risk of ischemic heart disease attributable to the major risk factors in a cohort of adult population
from Murcia (south-east Spain)
Risk factor Prevalence of exposition among the
population (%)
e
95% CI Relative
risk
f
95% CI Population attributable
risk (%)
95% CI
Hypercholesterolemia
a 27.5 25.3 -
29.7
2.02 1.13 -
3.62
21.9 2.1 -
41.7
Hypertriglyceridemia
b 16.5 14.6 -
18.5
1.85 1.06 -
3.25
12.4 0 - 25.6
Hypertension
c 22.2 20.3 -
24.1
3.21 1.61 -
6.42
32.9 10.7 -
55.1
Diabetes
d 6.2 4.9 - 7.6 1.68 0.86 -
3.29
4.0 0 - 10.5
Ever smoker 58.7 56.1 -
61.4
2.41 1.18 -
4.91
45.0 14.9 -
75.1
PAR: Population Attributable Risk.
aDefined as total serum cholesterol ≥240 mg/dl, prior diagnosis of hypercholesterolemia or prescribed use of lipid-lowering medication.
bDefined as serum triglyceride concentration ≥150 mg/dl.
cDefined as systolic blood pressure ≥140 mmHg, diastolic blood pressure ≥90 mmHg, prior diagnosis of hypertension or use of anti-hypertensive medication.
dDefined as a self-reported diagnosis of diabetes or prescription of insulin or oral anti-diabetic medication.
ePrevalence in the population of Murcia (20-70 years) standardized to the 2001 census population of the region (data from the DINO Study, 2002).
fRelative risk estimated as the hazard ratio of Cox models adjusted by all variables in the table, plus educational level, body mass index, and physical activity of
moderate or high intensity, and stratified by sex and age.
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Page 7 of 10study, except for tobacco use (relative risk = 2.60, 95%
CI: 1.75-3.85) in a sample of men and women attending
a primary care centre. Lower relative risks were also
reported by Tomàs i Abadal et al. [14] in a male occu-
pational cohort from north-east Spain. However, large
differences regarding the design, samples studied and
follow-up periods preclude direct comparisons with the
present study.
The major risk factors for stroke in this population
were smoking and hypertension. Evidence for stroke
associations with traditional risk factors exists in the lit-
erature [28], but as far as we know, this is the first pro-
spective study in Spain to present risk estimations of
cerebro-vascular disease by population levels of expo-
sure to CVRF. Diabetes was not a significant predictor
of stroke, although the possibility that such an associa-
tion could be detected with a prolonged follow-up time
and a larger number cases should not be discarded.
According to our results and most recent estimates of
CVRF prevalence [5], 45% of IHD cases were attributa-
ble to smoking, 33% to arterial hypertension, and 22%
to hypercholesterolemia (Table 4). Thus, hypertension
displaces hypercholesterolemia as the second leading
cause of CVD in this population. The limited number of
IHD cases warrants caution in the interpretation and
further generalization of results. Because of the high
proportion of population in Murcia exposed to tobacco
use, it would be expected from such initiatives as the
toughening of legislation on smoking (which came into
effect in the country since 2007) to have a large impact
on cardiovascular prevention in the region as well as the
rest of Spain. As compared with previous national esti-
mates of PAR of IHD, it is remarkable the role of hyper-
tension, as well as the lack of anthropometrical factors,
among the population determinants of risk [7]. Multi-
variate adjustment by intermediate variables such as
hypertension, hypertriglyceridemia and diabetes did
attenuate the estimated HR for categories of BMI,
although overweight and obesity neither were signifi-
cantly associated with CV risk in a univariate model
(data not shown). However, obesity was twice as high in
stroke cases than in non-cases (50% vs.2 1 . 8 % ;d a t an o t
shown), suggesting that the detection of an excess risk
associated with stroke in the obese might be constrained
by limited statistical power. The lack of predictive ability
of excess body weight on cardiovascular outcomes in the
present study should not be an obstacle for considering
obesity as one of the major health problems in the
region, where its prevalence is among the highest in
Spain and surrounding countries [29].
Some limitations should be considered. Despite the
long follow-up time, the study lacked power to provide
separate estimates for men and women, as it would be
advisable in order to better account for sex differences
in the morbi-mortality patterns of CVD [2,13]. The lack
of information on potential confounding factors, such as
diet or alcohol consumption [6,30], might also be a lim-
itation. There were fewer hypercholesterolemics and
more ever-smokers among participants lost to follow-up
[ A d d i t i o n a lF i l e1 :T a b l eS 1 ] ,b u ts i n c ew eh a v en o
information on the cardiovascular outcomes in these
participants we are unable to predict how this selection
bias could have affected the results. One fifth (21.6%) of
the initial sample refused to provide a blood specimen
or to undergo a physical examination. Albeit few com-
parisons are possible due to lack of relevant biochemical
and clinical information, these were in profile younger
men, more educated, with lower BMI and more prone
to engage in vigorous physical activity. No differences
were observed in smoking patterns. Except for age (con-
trolled for in the analyses), none of these factors was
found to significantly predict CVD, and therefore such a
selection bias would probably have had a minor effect
on the results.
The study has several important strengths, as the
population-based longitudinal design and the estimation
of PAR using regional-specific risks and prevalence data,
provides the first ever prospective results on the associa-
tion between CV outcomes and CVRF in the Region of
Murcia, and adds to the almost inexistent evidence yet
available in Spain. Our results show the extent to which
the effect of certain RF, particularly lipids, might be
overlooked when analysed in regard to global CV end-
points, as in the calibrated SCORE charts[9] recom-
mended for CV prevention in Spain [31]. We therefore
support the development of specific CV risk charts for
the primary prevention of IHD in Spain [8], and stress
the need for their validation with regional longitudinal
data that account for IHD variability in Spain.
In summary, our results provide prospective estimates
of coronary, cerebro-vascular and total CV risk in Mur-
cia, corroborate a relatively high incidence of AMI
within the Spanish context and underpin the importance
of promoting a non-smoking lifestyle as a key objective
for CV prevention.
Conclusions
Our study provides first-time population-based prospec-
tive estimates of IHD risk attributable to traditional
CVRF in Spain. Smoking and hypertension accounted
for most of the IHD risk, whereas hypercholesterolemia
was third in place. However, despite its very high preva-
lence among the population, obesity was not a signifi-
cant determinant of IHD or stroke in the region.
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